平安好醫生(01833.HK)不遠將來實現盈利屬預料之中續聚焦獲取醫療、患者流量
平安好醫生(01833.HK)董事長兼首席執行官王濤出席業績發布會時表示,考慮到上半年公司各業務指標,認為在不遠將來實現盈利是預料之中的事,他強調作為互聯網公司,平安好醫生成立僅五年,現時主要持續關注如何獲取更多醫療、患者流量,他又指公司的醫院雲、藥店雲、診所雲等都是圍繞獲取醫療流量的入口,相信未來兩至三年,將迎來互聯網醫療爆發式增長的重要窗口,當爆發機會來的時候,公司要做好充分準備。
他又指,據統計數據顯示,現時內地門診次數達80億次,未來期望有三成的門診流量可透過互聯網完成,而公司亦能在接觸面中排首位。
公司早期推出新產品「平安好醫生私家醫生」,王濤指出,相關產品於6月推出公測,最便宜版本收費為每年499元人民幣,認為是劃時代產品,令中產家庭可有自己的私家醫生,他又透露公司將於8月13日舉行發布會及簽約儀式,與包括中移動(00941.HK)在內等大型企業戰略合作,屆時會再公布簽約金額等。他又相信隨著家庭與醫生的交流和信任提升,以後相關產品對流量及收入均有重要貢獻。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.